Summary: Intercellular adhesion molecule-1 (ICAM-1), a raember of the immunoglobulin gene superfamily, is a cytokine-inducible adhesion molecule, which plays a central role in leukocyte migration into sites of acute or chronic inflammation. In this article we describe a sandwich immunoenzymometric method which allows rapid, semiquantitative (in "enzyme immunoassay units", EU) identification of ICAM-1 on the surface of alveolar macrophages. We evaluated this method in two groups of patients with pulmonary sarcoidosis (n = 12) or bacterial pneumonia (n = 11) and a group of healthy volunteers (n = 6), comparing the results with those obtained by immunocytochemical staining. ICAM-1 expression on the sarcoid alveolar macrophages surface was significantly elevated, s compared with control alveolar macrophages (0.76 EU ± 0.27 vs. 0.44 EU ± 0.12, p < 0.01). ICAM-1 expression on the surface of alveolar macrophages from patients with pneumonia was not elevated (0.48 EU ± 0.35). Stimulation with tumour necrosis factor-α (TNF-a) or interferon-γ (100 kU/1) led to a significant induction of ICAM-1 on the surface of control alveolar macrophages (0.76 EU ± 0.18, p < 0.005 for TNF-a, 0.64 EU ± 0.10, p < 0.005 for interferon-γ), whereas alveolar macrophages from both patient groups did not respond to cytokines even at high dosages. ICAM-1 expression on the surface of alveolar macrophages from patients with sarcoidosis correlated with the spontanepus release of TNF-α by macrophages (R = 0.77, p < 0.05). To summarize, the evaluation of ICAM-1 levels on the surface of cells harvested from the pulmonary c mpartment is a useful tool for interpreting the mechanisms leading to leukocyte cc mulation and activation in inflarnmatory disorders of the lung.
Introduction (5, 6) . Structurally, ICAM-1 is a member of the , ., ulm-hke domains (7) . Considermg current knowledge on kme-inducible adhesion molecule expressed on a wide · ' . Τ Λ Α Λ^ Λ Λ -· v ariety of cells at sites of inflammation (i, 2). It is the the ^n ctlo u n of IC^M -du ""g ^zmmMon, stud.es principal receptor for the integrin lymphocyte fonction K^dm^ the P osslble role of ICAM-1 express,on on the associated antigen-1 (3) aod mediales a n mfcer of adsurface of alveolar macrophages in the pathogenesis of hesion events among leukocytes and'between leukocytes inflammatory disorders of the lung are remarkably rare and other cells types (l, 4). ICAM-1 1 ) plays a major role ( Ihe surface of alveolar macrophages. We evaluated this method in two groups of patients with pulmonary sarcoidosis or bacterial pneumonia, comparing the results with those obtained from alveolar macrophages of healtliy volunteers. We examined both basal and stimulated ICAM-1 expression following 16 hours of incubation with interferon-γ or TNF-α. ICAM-1 expression in the sarcoidosis group was compared with TNF-α concentration in the supernatants of alveolar macrophages s an established characteristic of macrophage activity (10) . Patients suffering from pulmonary sarcoidosis were chosen because this disease provides an example of a strongly compartmentalized inflammatory disorder with accumulation of highly activated macrophages and lymphocytes in the lung (13) (14) (15) (16) (17) (18) (19) (20) . Patients with bacterial pneumonia were chosen because this disease, in contrast, is characterized by neutrophil accumulation in the pulmonary compartment. 
Materials and Methods

Reagents
Human recombinant tumour necrosis factor-α and human recombinant interferon-γ were obtained from Serva, Heidelberg, Germany. Stock Solutions of cytokines were stored aliquoted at -80 °C. The freeze-dried monoclonal mouse antibody against human ICAM-1 (clone 84H10) was purchased from Dianova, Hamburg, Germany. The antibody was reconstituted with phosphate-buffered saline (0. l mol/1, pH 7.2) containing l g/I bovine serum albumin (Serva, Heidelberg, Germany) and sodium azide (l g/l) to a final antibody concentration of 0.1 g/l. This stock solution could be stored at 4 °C for up to three months. Monoclonal antibodies against CD3, CD4, and CD8 were purchased from Dianova, Hamburg, Germany and Ortho Diagnostics, Beerse, Belgium, respectively. Peroxidase conjugated goat anti-mouse antibody was obtained from Sigma, Deisenhofen, Germany. Appropriate stock Solutions of these antibodies in l g/l bovine serum albumin were stored at 4 °C and dissolved in phosphate-buffered saline (0.1 mol/1, pH 7.2) for use in the experiments. The neutralizing anti-TNF-α antibody was obtained through H. Biermann, Bad Nauheim, Germany from British Biotechnology and was kept aliquoted at -20 °C. 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) diammonium salt (ABTS) was purchased from Sigma. Reagents for immunocytochemical staining were from Dako, Hamburg, Germany. All cell culture media and Supplements were obtained from Gibco, Eggenstein, Germany.
Study population
The study population consisted of 12 consecutive, untreated patients with active biopsy-proven sarcoidosis of the lung (radiological type I: n = 9, type II: n = 3) and 11 untreated patients with clinical and radiological signs of bacterial pneumonia. As controls, six healthy volunteers were studied. The three groups were comparable with respect to Smoking habits, which have been shown lo influence expression of adhesion molecules (21) .
Ethical committee approval and individual informed consent were obtained.
Clinical data and lavage cell characteristics are summarized in tablel.
Bronchoalveolar lavage and cell Isolation
Bronchoalveolar lavage was performed using a flexible fiberscope in the right middle lobe under Standard conditions (22) . Lavage volume was 200 ml with a ine n recovery of 84%, and was not statistically diiferent in patients and controls. The fifst 20 ml aliquot of the lavage, which is known to be contaminated with bronĉ hial secretions (23), was discarded and remaining portions were pooled. After evaluation of total cell count on a haemocytometer (Neubauer), lavage cell differentials were determined by WrightGiemsa staining of cytocentrifuge preparations (Cytospin II, Shandon). Cell viability was assessed nsirig trypan blue dye exclusion (88.7% ± 6.6 for all cases). For microscopical differentiation of lymphocyte subsets (CD3, CD4, CD8), fluorescein-conjug ted monoclonal antibodies were used. Lavage cells were washed twice using phosphate-buffered saline and resuspended at a viable alveolar macrophages concentration of 10 9 /1 in M199 supplemented with foetal calf serum (50 ml/l, Gibco), Z,-glutamine (2 mmol/1, Gibco) and penicillin/streptomycin (l g/l, Gibco).
ICAM-l expression on the surface of alveolar macrophages ICAM-1 expression on the surface of alveolar macrophages was determined using an immunoenzymometric assay teohnique. Mononuclear lavage cells containing viable alveolap macroph' ges at a density of 10 9 /1 were seeded into 96-well flat bottom microtitre plates (100 μΐ/well) for three hours (37 °C, 5% CO 2 ) to allow the macrophages to adhere. We chose this cell concentrations from the linear portion of the cell number/absorbance curve. Non-adherent cells were removed by gently washing three times with warm cell culture medium. Serum-supplemented M199 (100 μΐ/well) with or without 100 kU/1 interferon-γ or TNF-α was added. Incubation was continued for 16 hours at 37 °C in a totaHyJhumidified atmosphere containing 5% CO 2 . At the end of the inc bation time cells were washed twice and fixed with 10 g/l paraformaldehyde (l h, 21 °C). After washing the fixed cells t ree times with phosphate-buffered saline (0.1 mol/1, pH 7.2) free birtding sites were blocked by adding a 20 g/l solution of bovine serum albumin dil ted in phosphatebuffered saline, 0. l mol/1 for l -houtit 37 °C. The blocking solution was removed by Inversion of the microtitre plate and gently tapEur. J. Clin. Chem. Clin. Biochem. / Vol. 32,19947 No. 6 -l i ping it on a soft paper tissue. A total of 100 μΐ of the monoclonal mousc anti-ICAM-1 antibody in an antigen-saturating concentration (l : 1000, containing l g/l bovine serum albumin) was added to each well for two hours at 37 °C. At the end of the two hours, plates wcre washed three times and 100 μΐ of the developing antibody was added (peroxidase conjugated goat anti-mouse antibody, l : 1000, containing l g/l bovine serum albumin). After incubating the plates for l hour at 37 °C, the enzyme conjugate was removed and plates were washed four times with phosphate-buffered saline. Finally ABTS (l g/l) and hydrogen peroxide (2.8 μΐ 300 g/kg H 2 O 2 per 10 ml) in 0.1 mol/1 sodium acetate, (pH 4.2) was added. The colour was allowed to develop for 120 minutes and plates were read with a microplate reader (Behring EL 311) at 405 nm. Appropriate controls were included in each assay. These include omission of the primary antibody and/or the developing antibody and/or the Substrate or the cells. Non-specific binding of the primary monoclonal mouse antibody to alveolar macrophages was quantified using mouse IgGi instead of the anti-ICAM-1 antibody. Results are expressed s enzymeimmunoassay units (EU) from quadruplicate wells calculated s the difference of absorbances (ΔΑ 40 Immunocytochemical staining was performed using the alkaline phosphatase monoclonal mouse anti-alkaline phosphatase complex s described (25) . Briefly, frozen slides were warmed to room temperature before unwrapping, After fixing the cells for 2 min with pure acetone and washing with Tris^buffered saline (pH 7.6), slides were incubated for 30 min at 21 °C with 200 μΐ of the monoclonal anti-ICAM-1 antibody (l : 25) in a humidified chamber.
The primary antibody was removed and slides were washed twice before adding 200 μί of a rabbit anti-mouse antibody for 30 min.
After two washings with Tris-buffered saline slides were incubated with 200 μΐ of a l : 50 dilution of the alkaline phosphatase monoclonal mouse anti-alkaline phosphatase complex.
The alkaline phosphatase product was visualized using a naphthol AS-MX phosphate fast red solution (Sigma, Deisenhofen, Germany), containing l mol/1 levamjsole to inhibit endogenous alkaline phosphatase. Finally, slides were coutterstained with haemalaun (20 min) and blued under running tap water (10 min).
Tumour necrosis factor-α bioassay
For determination of TNF-α, alveolar macrophages from patients with sarcoidosis and healthy volunteers were cultured in 96-well microtitre plates s described above. After removing non-adherent ceils 100 μΐ fresh Ml99 supplemented with 50 ml/l foetal calf seruni was added to each well. Supernatants were removed from at least 6 wells after 60 min (37 °C). Samples from triplicate wells were pooled into one tube and immediately frozen at -20 °C. TNF-α was measured using a L929 fibroblast lytic assay s prcviously described (26) . Briefly, L929 cells (60000/well) were cultured in 96-well flat'bottom microtitre plates (Nunc) containing threefoid serial dilutions of conditioned supernatant of sarcoid alveolar macrophages, in the presence of actinomycin D (l mg/J, total assay v lume: 200 μΐ/well). After 20 hours of incubation, the renoaining L929 cells were stained with crystal ! violet. The TNF-a concentration of the triplicate samples was quantified by comparing the results with the linear portion of a Standard curve, pbtained with human recombinant TNF-a (6.6 X l O 6 kU/g). The specificity of this bioassay was tested by neutralizing peak samples with a goat anti-human-TNF-α antibody (0.1-100 mg/1).
Statistics
Non-parametric statistics were used throughout the study. The Wilcoxon signed rank test was used for paired samples and the MannWhitney Uztest for independent samples. Correlations were madc with the Spearman rank correlation. The median was used s a marker of central tendency. Differences were considered statistically significant per p < 0.05 (27) .
Results
Total and differential cell count Table l shows the lavage cell characteristics. As expected, the total number of recovered bronchoalveolar lavage cells was increased in both patient groups. The percentage of lymphocytes in the sarcoidosis group was significantly increased, compared with healthy controls (p < 0.005). In patients with pneumonia, neutrophils but not lymphocytes were significantly increased in bronchoalveolar lavage.
Expression of ICAM-1 on alveolar macrophages
Using the immunoenzymometric assay, ICAM-1 expression on the surface of alveolar macrophages was deControl Pneumonia Sarcoidosis tected in all cases (flg. 1). Specific antibody binding was determined for each patient/control by subtracting nonspecific binding of mouse IgG, to alveolar macrophages ( fig. 2) . In all cases absorbance due to non-specific binding did not exceed 10% of maximum absorbance obtained after addition of the specific anti-IC AM-1 antibody. We found significantly elevated ICAM-1 expression on the surface of sarcoid alveolar macrophages, compared with those of healthy controls (0.76 EU ±0.27 vs. 0.44 EU ±0.12, p < 0.01). In contrast, ICAM-1 expression on the surface of alveolar macrophages from patients with pneumonia was not elevated (0.48 EU ± 0.35, p = not significant).
ICAM-1 expression on the surface of alveolar macrophages from healthy volunteers was augmented after Stimulation with interferon-γ or TNF-α ( fig. 1 ). In three controls, a dose dependent increase of ICAM-1 expression was demonstrated ( fig. 3 ). However patients' alveolar macrophages did not respond to cytokines even at high doses (500 kU/1 interferon-γ or 500 kU/1 TNFa, data not shown). Irnmunocytochemical staining on cytocentrifuge preparations correlated with the results obtained with the imm noenzymometric assay method. In pulmon ry s rcoidosis the number of visibly stained cells was significantly elevated when compared with healthy volunteers (78% ± 11 vs. 40% ± 8 positive cells, p < 0.05). Furt hermore, we observed that staining of patients' alveolar macrophages resulted in more intense colouring of the cells than immunocytochemical staining of control alveolar macrophages ( fig. 4 ).
Tumour necrosis factor-α bioassay
The black part of column 4 corresponds to the expression of the ICAM-1 on the cell surface.
was determined in the supernatants of alveolar macrophages. All sarcoid alveolar macrophages spontaneously released TNF-α, whereas only low TNF-a concentration could be detected in the supernatants of controls. TNF-α concentrations in patients ranged from 5-1375 kU/1 reflecting different stages of activity of the disease. TNF-α concentration in the supernatants of sarcoid alveolar macrophages correlated with the· ICAM-1 surface expression of these cells (r s? 0.-77, p < 0.05; 10). TNF-α was not determined in bacterial pneumonia.
Discussion
We desoribe a method for the rapid, semi-a t m tic identification of IC M-1 on the surface of alveolar macrophages. Our results correlate with those obtained by immunocytochemical staining, a technique which has been used previously to esttoate surface expression of adhesion molecules on lveot r macroplaages (8, 9). We did not directly compare our ELISA with flow eytometric methods, which can also be used for detection of cell surface markers. Flow cytometry is widely established for lymphocyte typing and provides the advantage of testing more than one antibody on identical cells. However alveolar macrophages show high background fluorescence, which interferes with the specific signal, esp ecially when low receptor expression is expected (28) . In this fespect, we fouüd the immunoenzymometric assay to be very precise, allowing the quantification of small differences in ICAM^l expression that are difficult to assess by microscopic aiiälysis. The use of a microplate reader for measuring the indicator enzyme activity at the end of the experiment is not only convenient but leads to more objective quantitative results than those obtained by microscopic evaluation of cell stains. In addition, large numbers of cells can be analysed in one experiment (e. g. investigation of 10 wells of a microtitre plate equals the analysis of 10 X l O 5 cells), which leads to highly reproducible results. Furthermore, differences in the colour intensity of the immunocytochemically stained cells are not quantifiable by microscopic evaluation. We observed marked Variation in this respect between patient samples and controls, which may reflect up-regulation of the number of binding sites expressed per cell (1).
Finally, the immunoenzymometric assay provides a setting suitable for studying inodulatory effects of cytokines or other agents on the expression of ICAM-1 on the surface of alveolar macrophages in vitro. In summary we see this method äs an approach to a better semi-quantitative identification of adhesion molecules on the surface of alveolar raacrophages, compared with conventional immunocytochemical staining.
The main finding of the clinical part of this study was that ICAM-1 expression on the surface of alveolar macrophages is differently regulated in patients with sarcoidosis (mononuclear cell alveolitis) and bacterial pneumonia (neutrophil alveolitis). Sarcoid alveolar macrophages expressed significantly higher amounts of ICAM-1 than macrophages of healthy volunteers. Our data are consistent with recent work demonstrating increased expression of ICAM-1 on the surface of alveolar macrophages from patients with pulmonary sarcoidosis using immunocytochemical staining (8, 9) . We fiirther demonstrated that ICAM-1 expression of control alveolar macrophages can be significantly increased by Stimulation with either TNF-or interferon-. It has been demonstrated previously that ICAM-1 expression can be induced by cytokines on various cell types (1), but no data were hitherto available on the in vitro induction of ICAM-1 on the surface of alveolar macrophages. In contrast, ICAM-1 expression on the surface of alveolar macrophages from patients with bacterial pneumonia was not elevated, proving that upregulated ICAM-1 expression is not an unspecific finding in pulmonary inflammation. In the light of present knowledge, ICAM-1 expression on the alveolar macrophages surface seems to be crucial in the pathogenesis of lymphocyte accumulation and activation in the pulmonary compartment (10, 29) . In neutrophil alveolitis different mechanisms of bronchoalveolar cell activation are likely to be involved.
Since alveolar macrophages can be harvested in large numbers from sites of disease activity by bronchoalveolar lavage, rapid and reliable identification of adhesion molecules such äs ICAM-1 on the surface of cells from the pulmonary compartment might be a useful tool for further elucidation of the pathogenesis of these diseases.
